UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular Basis for Cyclooxygenase Inhibition by the Non-steroidal Anti-inflammatory Drug Naproxen

The Journal of biological chemistry, 2010-11, Vol.285 (45), p.34950-34959

2010

Volltextzugriff (PDF)

Fabrication of PES/PVP Water Filtration Membranes Using Cyrene®, a Safer Bio-Based Polar Aprotic Solvent

Advances in polymer technology, 2019, Vol.2019 (2019), p.1-15

2019

Volltextzugriff (PDF)

Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers

Investigational new drugs, 2019-08, Vol.37 (4), p.711-721

2019

Volltextzugriff (PDF)

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease

The Journal of pharmacology and experimental therapeutics, 2010-10, Vol.335 (1), p.61-69

2010

Volltextzugriff (PDF)

Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes

Metabolism, clinical and experimental, 2013-11, Vol.62 (11), p.1623-1632

2013

Volltextzugriff (PDF)

Harmful and Potentially Harmful Constituents in E‑Liquids and Aerosols from Electronic Nicotine Delivery Systems (ENDS)

Chemical research in toxicology, 2024-07, Vol.37 (7), p.1155-1170

2024

Volltextzugriff (PDF)

A systemically-administered small molecule antagonist of CCR9 acts as a tissue-selective inhibitor of lymphocyte trafficking

PloS one, 2012-11, Vol.7 (11), p.e50498-e50498

2012

Volltextzugriff (PDF)

CCR9 Antagonists in the Treatment of Ulcerative Colitis

Mediators of Inflammation, 2015-01, Vol.2015 (2015), p.1-10

2015

Volltextzugriff (PDF)

CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease

American journal of physiology: Gastrointestinal and liver physiology, 2018-04, Vol.314 (4), p.G483-G493

2018

Volltextzugriff (PDF)

Cigarette Smoke Activates Human Monocytes by an Oxidant-AP-1 Signaling Pathway: Implications for Steroid Resistance

Molecular pharmacology, 2005-11, Vol.68 (5), p.1343-1353

2005

Volltextzugriff (PDF)

Determination of Aflatoxin B1 in Smokeless Tobacco Products by Use of UHPLC-MS/MS

Journal of agricultural and food chemistry, 2015-10, Vol.63 (41), p.9131-9138

2015

Volltextzugriff (PDF)

Bacterial Populations Associated with Smokeless Tobacco Products

Applied and environmental microbiology, 2016-10, Vol.82 (20), p.6273-6283

2016

Volltextzugriff (PDF)

Mainstream Smoke Levels of Volatile Organic Compounds in 50 U.S. Domestic Cigarette Brands Smoked With the ISO and Canadian Intense Protocols

Nicotine & tobacco research, 2016-09, Vol.18 (9), p.1886-1894

2016

Volltextzugriff (PDF)

Discovery of AB680: A Potent and Selective Inhibitor of CD73

Journal of medicinal chemistry, 2020-10, Vol.63 (20), p.11448-11468

2020

Volltextzugriff (PDF)

Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity

Molecular cancer therapeutics, 2022-06, Vol.21 (6), p.948-959

2022

Volltextzugriff (PDF)

Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels

Immunology, 2014-01, Vol.141 (1), p.111-122

2014

Volltextzugriff (PDF)

Fc-silent anti-TIGIT antibodies potentiate anti-tumor immunity without depleting regulatory T cells

Cancer research (Chicago, Ill.), 2024-04

2024

Volltextzugriff (PDF)

Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors

Molecular cancer therapeutics, 2024-05

2024

Volltextzugriff (PDF)

Discovery of Potent and Selective PI3Kγ Inhibitors

Journal of medicinal chemistry, 2020-10, Vol.63 (19), p.11235-11257

2020

Volltextzugriff (PDF)

Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)

Journal of medicinal chemistry, 2022-01, Vol.65 (2), p.1418-1444

2022

Volltextzugriff (PDF)

A Survey of N′‑Nitrosonornicotine (NNN) and Total Water Content in Select Smokeless Tobacco Products Purchased in the United States in 2015

Journal of agricultural and food chemistry, 2016-06, Vol.64 (21), p.4400-4406

2016

Volltextzugriff (PDF)

Harmful and Potentially Harmful Constituents in the Filler and Smoke of Tobacco-Containing Tobacco Products

ACS omega, 2022-07, Vol.7 (29), p.25537-25554

2022

Volltextzugriff (PDF)

Multivariate Statistical Analysis of Cigarette Design Feature Influence on ISO TNCO Yields

Chemical research in toxicology, 2016-06, Vol.29 (6), p.1051-1063

2016

Volltextzugriff (PDF)

793 Combined administration of the dual A2aR/A2bR antagonist etrumadenant with a reduced chemotherapy regimen leads to enhanced tumor efficacy and survival

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A890-A890

2023

Volltextzugriff (PDF)

Discovery of Potent and Selective 7‑Azaindole Isoindolinone-Based PI3Kγ Inhibitors

ACS medicinal chemistry letters, 2020-11, Vol.11 (11), p.2244-2252

2020

Volltextzugriff (PDF)

1 – 25 von 899

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(745)
Mit Volltextzugriff
(745)

Publikationsform

Sprache

Englisch
(899)
Japanisch
(145)
Norwegisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(658)
Life Sciences & Biomedicine
(502)
Humans
(408)
Female
(203)
Male
(194)
Middle Aged
(130)
Aged
(127)
Physical Sciences
(123)
Adult
(107)
Biological And Medical Sciences
(87)
Animals
(73)
Medical Sciences
(71)
Neurosciences & Neurology
(68)
Risk Factors
(68)
General & Internal Medicine
(64)
Technology
(58)
Clinical Neurology
(53)
Surgery
(53)
Science & Technology - Other Topics
(52)
Medicine, General & Internal
(51)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Stroke
(21)
Nature Genetics
(18)
Plos One
(17)
The New England Journal Of Medicine
(17)
Cancer Research
(15)
The Astrophysical Journal
(14)
Nature
(12)
American Journal Of Obstetrics And Gynecology
(11)
Astrophysical Journal/the astrophysical Journal
(11)
Nature Communications
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Molecular Basis for Cyclooxygenase Inhibition by the Non-steroidal Anti-inflammatory Drug Naproxen

Fabrication of PES/PVP Water Filtration Membranes Using Cyrene®, a Safer Bio-Based Polar Aprotic Solvent

Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease

Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes

Harmful and Potentially Harmful Constituents in E‑Liquids and Aerosols from Electronic Nicotine Delivery Systems (ENDS)

A systemically-administered small molecule antagonist of CCR9 acts as a tissue-selective inhibitor of lymphocyte trafficking

CCR9 Antagonists in the Treatment of Ulcerative Colitis

CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease

Cigarette Smoke Activates Human Monocytes by an Oxidant-AP-1 Signaling Pathway: Implications for Steroid Resistance

Determination of Aflatoxin B1 in Smokeless Tobacco Products by Use of UHPLC-MS/MS

Bacterial Populations Associated with Smokeless Tobacco Products

Mainstream Smoke Levels of Volatile Organic Compounds in 50 U.S. Domestic Cigarette Brands Smoked With the ISO and Canadian Intense Protocols

Discovery of AB680: A Potent and Selective Inhibitor of CD73

Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity

Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels

Fc-silent anti-TIGIT antibodies potentiate anti-tumor immunity without depleting regulatory T cells

Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors

Discovery of Potent and Selective PI3Kγ Inhibitors

Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)

A Survey of N′‑Nitrosonornicotine (NNN) and Total Water Content in Select Smokeless Tobacco Products Purchased in the United States in 2015

Harmful and Potentially Harmful Constituents in the Filler and Smoke of Tobacco-Containing Tobacco Products

Multivariate Statistical Analysis of Cigarette Design Feature Influence on ISO TNCO Yields

793 Combined administration of the dual A2aR/A2bR antagonist etrumadenant with a reduced chemotherapy regimen leads to enhanced tumor efficacy and survival

Discovery of Potent and Selective 7‑Azaindole Isoindolinone-Based PI3Kγ Inhibitors

Suchergebnisse filtern